The specifi c genetic programs guide the formation and development of the embryonic head. Abnormal orofacial structures are seen as a result of changes in the genetics and environmental factors. The examples seen routinely in dental clinics include orofacial clefts. Therefore, the development of the therapies for orofacial pathological conditions depend very much on thorough and detailed knowledge about the molecular and cellular processes which are involved in the head formation.
Introduction
During embryogenesis, any disturbance in the normal development of head gets manifested as orofacial malformations. The analysis of the genetic code responsible for these disorders has allowed to the availability of genetic markers across the human genome. These defects could also be identifi ed by the advancements in the fi eld of cloning and sequencing. Furthermore, understanding the animal models have provided an invaluable tool for understanding the molecular processes that govern the development of the head.
Head Formation
The formation of the head is a complex process, which occurs under strict genetic control program which appears to be highly conserved among all the vertebrates occurring at the earliest stages of the human embryonic development. [1] cranial neural crest (CNC) cells are a group of stem cells which are supposedly responsible for head formation. [1] These cells, after getting detached from the lateral ridges of the neural plate migrate toward the developing branchial arches. The proliferation of the CNC cells is responsible for the budding of tissues around the future oral cavity such as frontonasal process and maxilla-mandibular processes. These processes join and fuse at a later stage giving rise to the completed face, including the formation of teeth in both the maxillary and mandibular processes.
Gene mutations along with environmental factors can aff ect the expression of genes or interfere with the normal function of their protein products. These proteins are responsible for diff erentiation of cells into specifi c cell types such as osteoblasts, odontoblasts, and odontoclasts. Mutations in the gene sequencing can cause disturbances in the both expression and function of encoded proteins thus can lead to various orofacial disorders.
Growth and Transcription Factors
The growth factors involved in orofacial development belong mainly to four families that are well conserved between diff erent species: The fi broblast growth factor (FGF) family, the wingless (WNT) family, the hedgehog (HH) family, and the transforming growth factor beta (TGF-β) family. The phenotypic changes
resulting due to mutations occurring in the genes of the signaling pathways are often comparable between humans and other vertebrates like a mouse.
FGF-Pathway
The FGF signaling pathway is active in both the facial epithelium and mesenchyme and is mainly involved in stimulating cell proliferation. Mutations in FGF molecules or their receptors usually result in craniosynostosis. [2, 3] 
HH-Pathway
This sonic HH (SHH) factor is responsible for the development of face [4] by expressing itself in the ectoderm of the frontonasal process. As a result, any mutations in it can result in holoprosencephaly. It is also responsible for expression of GorlinGoltz syndrome as a result of mutations showing hypodontia along with clefts [5] on the other hand, its overexpression can lead to midfacial widening representing hypertelorism.
WNT-Pathway
During early craniofacial development in the mouse embryo, members of the WNT family are expressed at tooth initiation sites, and at sites of bone formation of both the jaws. Under expression of this factor causes abnormally reduced the growth of the face [6] along with cleft lip and or palate. [7] 
TGF-Pathway
This factor is the much deciding factor in the molecular cascade of the craniofacial development. As a result, its underexpression results in mutations causing uni or bilateral clefts in the upper lip. Mutations in receptor TGF-β receptor (TGF-R2) or TGF-R3 can cause hypertelorism, bifi d uvula, and cleft palate. [8] Genetic Abnormalities Associated with Oral Clefts in Humans TGF-β has been shown to be involved in oral cleft formation in humans. [9] It is also found that conditional inactivation of a TGF-R2 in the neural crest cell population causes cleft palate in mice. [10] The resulting mutant embryos showed facial asymmetry, micrognathia, smaller tongue and palatal shelves that are not elevated over the tongue, suggesting that TGF-R2 plays a very important role in orofacial development. It is also found that growth factor BMP7, another member of the TGF-β family, causes clefts in the soft, and hard palate along with defects in tooth development. [11] 
Clinical Relevance of the Genetic Findings
The advancements made toward genetic engineering using stem cells could therefore would provide the best possible treatment options to the aff ected individuals with genetic mutations thus allowing the use of such biological structures close to the resembling the malformed structure and suitable for clinical applications. There is a signifi cant development that shows that as our knowledge on the genetic programs responsible for tooth formation has increased the possibility of directing stem cells toward forming an entire functional organ by mimicking embryonic developmental processes in the near future. [12] Conclusions A detailed knowledge of the genetic processes is involved in the formation of orofacial structures. The development of novel clinical therapies for orofacial abnormalities, such as clefts and tooth agenesis, depend very much on genetic information. Therefore, it can be concluded that intense research in the fi eld of developmental biology could be directed toward providing clinical benefi ts to such mutant individuals thus providing them maximum functional and esthetic benefi ts.
